Santos-Hernández JE, Macedo-Montero MG, Zepeda-López A, Reyes-Gómez U, Reyes-Hernández KL, Acosta-Rubio CQ

Language: Spanish
References: 15
Page: 148-151
PDF size: 307.81 Kb.

ABSTRACT

Skin and soft tissue infections are one of the main reasons for consultation and hospitalization. Ten percent of hospitalizations associated with infectious processes correspond to skin and soft tissue infections. These infections are classified according to the extension, such as complicated and uncomplicated; with respect to time, acute or chronic and finally necrotizing or non-necrotizing. Among uncomplicated soft tissue infections, impetigo, folliculitis, erysipelas, ecthyma and cellulitis stand out. The so-called complicated ones are those that invade deep tissues such as abscesses. The main etiological agents are Staphylococcus aureus and Streptococcus pyogenes. The early initiation of antibiotic therapy directed against these two microorganisms will guarantee the prompt resolution of the infectious process. Universally, the treatments with the highest success rate are penicillinase-resistant penicillins, first-generation cephalosporins or macrolides. In the case of methicillin-resistant S. aureus, vancomycin is considered the first choice and linezolid as an alternative.

REFERENCES

1. Addison, K.M., “Skin and soft tissue infections”, SurgClin N Am, 2009, 89: 403-420.

2. Moyano, M., Peuchot, A. y Giachetti, A.C., “Infeccionesde piel y partes blandas en pediatría: consenso sobrediagnóstico y tratamiento”, Arch Argent Pediatr, 2014,112 (1): e96-e112.

3. Mandell, G.L., Bennett, J.E y Dolin, R., Principles andpractice of infectious diseases, 7ª ed., Elsevier, 2012, pp.1333-1355.

4. Stevens, D.L., Bisno, A. y Chambers, F., “Practice guidelinesfor the diagnosis and management of skin andsoft tissue infections: 2014”, Update by the InfectiousDiseases Society of America, idsa Practice Guidelines forsstis-cid 2014: 59.

5. Pérez de la O, A.D. y García, R., “Impétigo ampolloso. CriterioPediátrico”, Acta Pediatr Mex, 2017, 38 (5): 351-354.

6. Baptista, L., “Impétigo-review”, An Bras Dermatol,2014, 89 (2): 293-299.

7. Arenas, R., Dermatología. Atlas, diagnóstico y tratamiento,6ª ed., México McGraw Hill, 2015, pp. 392-394.

8. Esposito, S., Bassetti, M. y Concia, E., “Diagnosis andmanagement of skin and soft-tissue infections (ssti). Aliterature review and consensus statement: an update”,J Chemother, 2017, 29 (4): 197-214.

9. Gunderson, C., “Celulitis: definición, etiología y manifestacionesclínicas”, Am J Med, 2011; 124: 1113-1122.

10. Blackberg, A. y Trell, K., “Erysipelas, a large retrospectivestudy of etiology and clinical presentation”, InfectiousDiseases, 2015, 15: 402-404.

11. Inghammar, M., “Recurrent erysipelas: risk factors andclinical presentation”, bmc Infectious Diseases, 2014, 14:270.

12. Fica, A., “Celulitis y erisipela: manejo en atención primaria”,Rev Chil Infect, 2003, 20 (2): 104-110.

13. Moyano, M., Peuchot, A. y Giachetti, A.C., “Infeccionesde piel y partes blandas en pediatría: consenso sobrediagnóstico y tratamiento”, Arch Argent Pediatr, 2014,112 (2): 183-191.

14. Vichitra, S. y Senanayake, S., “Bacterial skin and soft tissueinfections”, Aust Prescr, 2006, 39 (5): 159-163.

15. Ramakrishnan, R., “Skin and soft tissue infections”,American Family Physician, 2015, 92: 474-86. www.aafp.org/afp.